USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in

Sheng Li1,2, Situ Xiong1,2, Zhongqi Li1,2

  • 1Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Cell Death & Disease
|November 5, 2024
PubMed

Insights

The deubiquitinating enzyme USP3 stabilizes SMARCA5, promoting DNA repair and chemotherapy resistance in prostate cancer. Targeting the USP3-SMARCA5 axis may improve treatment for resistant cancers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • SMARCA5 is crucial for DNA repair and its dysfunction causes neurodevelopmental disorders.
  • The regulation of SMARCA5 in prostate cancer (PCa) is not well understood.
  • Understanding SMARCA5 regulation is vital for developing new PCa therapies.

Purpose of the Study:

  • To elucidate the molecular mechanism regulating SMARCA5 stability in prostate cancer.
  • To investigate the role of USP3 in SMARCA5 regulation and its impact on chemotherapy resistance.
  • To explore the therapeutic potential of targeting the USP3-SMARCA5 axis in prostate cancer.

Main Methods:

  • Investigated the interaction between USP3 and SMARCA5 using biochemical assays.
  • Assessed the effect of USP3 on SMARCA5 ubiquitination and stability.
  • Utilized in vitro and in vivo models to evaluate the role of USP3 and SMARCA5 in docetaxel resistance.
  • Analyzed clinical prostate cancer tissues to correlate USP3 and SMARCA5 expression.

Main Results:

  • USP3 directly interacts with SMARCA5 and removes its K63-linked polyubiquitination, enhancing SMARCA5 stability.
  • Depletion of USP3 or SMARCA5 increased sensitivity of PCa cells to docetaxel.
  • Overexpression of USP3 conferred docetaxel resistance in SMARCA5-silenced cells.
  • USP3 is upregulated in PCa tissues and positively correlates with SMARCA5 expression.

Conclusions:

  • USP3 stabilizes SMARCA5, promoting DNA double-strand break (DSB) repair and docetaxel resistance in prostate cancer.
  • The USP3-SMARCA5 axis is a key regulator of DNA repair and chemotherapy response.
  • Targeting the USP3-SMARCA5 axis presents a promising therapeutic strategy for chemotherapy-resistant prostate cancer.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
34.2K